- Home
- ARVN vs IPI Comparison
ARVN vs IPI Comparison
Compare ARVN & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- IPI
- Stock Information
- Founded
- ARVN 2015
- IPI 2000
- Country
- ARVN United States
- IPI United States
- Employees
- ARVN N/A
- IPI N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- ARVN Health Care
- IPI Industrials
- Exchange
- ARVN Nasdaq
- IPI Nasdaq
- Market Cap
- ARVN 456.2M
- IPI 518.6M
- IPO Year
- ARVN 2018
- IPI 2008
- Fundamental
- Price
- ARVN $7.80
- IPI $34.96
- Analyst Decision
- ARVN Buy
- IPI Strong Sell
- Analyst Count
- ARVN 21
- IPI 1
- Target Price
- ARVN $20.53
- IPI $19.00
- AVG Volume (30 Days)
- ARVN 2.2M
- IPI 152.0K
- Earning Date
- ARVN 07-29-2025
- IPI 08-04-2025
- Dividend Yield
- ARVN N/A
- IPI N/A
- EPS Growth
- ARVN N/A
- IPI N/A
- EPS
- ARVN N/A
- IPI N/A
- Revenue
- ARVN $426,900,000.00
- IPI $217,865,000.00
- Revenue This Year
- ARVN $4.26
- IPI $11.06
- Revenue Next Year
- ARVN N/A
- IPI N/A
- P/E Ratio
- ARVN N/A
- IPI N/A
- Revenue Growth
- ARVN 498.74
- IPI N/A
- 52 Week Low
- ARVN $5.90
- IPI $20.75
- 52 Week High
- ARVN $34.11
- IPI $39.01
- Technical
- Relative Strength Index (RSI)
- ARVN 58.03
- IPI 43.36
- Support Level
- ARVN $7.09
- IPI $34.13
- Resistance Level
- ARVN $7.85
- IPI $38.48
- Average True Range (ATR)
- ARVN 0.40
- IPI 1.40
- MACD
- ARVN 0.06
- IPI -0.33
- Stochastic Oscillator
- ARVN 71.43
- IPI 25.27
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About IPI Intrepid Potash Inc
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.